References
- Malbon C C, Tao J, Wang H Y. AKAPs (A-kinaseanchoring proteins) and molecules that compose their G-protein-coupled receptor signaling complexes. Biochem J 2004; 379: 1–9
- Choi M C, Jong H S, Kim T Y, Song S H, Lee D S, Lee J W, Kim T Y, Kim N K, Bang Y J. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004; 23: 7095–7103
- Boultwood J, Pellagatti A, Watkins F, Campbell L J, Esoof N, Cross N CP, Eagleton H, Littlewood T J, Fidler C, Wainscoat J S. Low expression of the putative tumor suppressor gene Gravin in chronic myeloid leukemia, myelodysplastic syndromes and acute myeloid leukemia. Br J Hematol 2004; 126: 508–551
- Nauert J B, Klauck T M, Langeberg L K, Scott J D. Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 1997; 7: 52–62
- Grove B D, Bruchey A K. Intracellular distribution of gravin, a PKA and PKC binding protein, in vascular endothelial cells. J Vasc Res 2001; 38: 163–175
- Gelman I H. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci 2002; 1782–1797
- Gelman I H, Gao L. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways. Mol Cancer Res 2006; 4: 151–158
- Xia W, Unger P, Miller L, Nelson J, Gelman I H. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res 2001; 61: 5644–5651
- Wikman H, Kettunen E, Seppanen J K, Karjalainen A, Hollmen J, Anttila S, Knuutila S. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 2002; 21: 5804–5813
- Wasenius V M, Hemmer S, Kettunen E, Knuutila S, Franssila K, Joensuu H. Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 2003; 9: 68–75
- Lahav R, Suva M L, Rimoldi D, Patterson P H, Stamenkovic I. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 2004; 64: 8945–8953
- Huang S, Podsypanina K, Chen Y, Cai W, Tsimelzon A, Hilsenbeck S, Li Y. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles. Technol Cancer Res Treat 2006; 5: 565–571
- Frankfort B J, Gelman I H. Identification of novel cellular genes transcriptionally suppressed by v-src. Biochem Biophys Res Commun 1995; 206: 916–926
- Heintel D, Kienle D, Shehata M, Krober A, Kroemer E, Scwarzinger I, Mitteregger D, Le T, Gleiss A, Mannhalter C, Cott A, Schwarzimer J, Fonatsch C, Gaiger A, Dohner H, Stilgenbauer S, Jager U, CLL Study Group. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216–1223
- Bilban M, Heintel D, Scharl T, Woelfel T, Auer M M, Porpaczy E, Kainz B, Krober A, Carey V J, Shehata M, Zielinski C, Pickl W, Stilgenbauer S, Gaiger A, Wagner O, Jager U, German CLL Study Group. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080–1088
- Schorr K, Li M, Krajewski S, Reed J C, Furth P A. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia 1999; 4: 153–164
- Martinez-Arribas F, Alvarez T, Del Val G, Martin-Garabato E, Nunez-Villar M J, Lucas R, Sanchez J, Tejerina A, Schneider J. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein Level. Anticancer Res 2007; 27: 219–222
- Gurova K V, Gudkov A V. Paradoxical role of apoptosis in tumor progression. J Cellular Biochem 2003; 88: 128–137
- Gebauer S, Yu A L, Omura-Minamisawa M, Batova A, Dicciani M B. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer 2004; 41: 297–308